Skip to main content

PGT-M conditions

This table shows all PGT-M conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact pgtm@hfea.gov.uk.

Download full approved condition list.

Condition name Status OMIM number Documents
Mitochondrial Trifunctional Protein Deficiency approved 609015
Molybdenum Cofactor Deficiency Type B (MOCODB) approved 252160
Muckle-Wells Syndrome (MWS) approved 191900
Mucolipidosis type II approved 252500
Mucopolysaccharidosis III (MPS-III) Type A (Sanfilippo syndrome A) approved 252900
Mucopolysaccharidosis III (MPS-III) Type B approved 252920
Mucopolysaccharidosis III (MPS-III) Type C approved 252930
Mucopolysaccharidosis III (MPS-III) Type D approved 252940
Mucopolysaccharidosis IVA approved 253000
Mucopolysaccharidosis Type I (MPS I) approved 607014, 607015, 607016
Mucopolysaccharidosis Type II (Hunter Syndrome) approved 309900
Mucopolysaccharidosis Type IVB (MPS4B) approved 253010
Mucopolysaccharidosis Type VI (MPS VI) (Maroteaux-Lamy Syndrome) approved 253200
Mucopolysaccharidosis Type VII (MPS7) approved 253220
Muenke Syndrome (MNKES) approved 602849
Multiple acyl-CoA dehydrogenase deficiency (MADD) (also known as glutaric aciduria type II) approved 231680
Multiple Congenital Anomalies Hypotonia – Seizures Syndrome 1 (MCAHS1) approved 614080
Multiple Congenital Anomalies Hypotonia – Seizures Syndrome 2 (MCAHS2) approved 300868
Multiple Congenital Anomalies Hypotonia – Seizures Syndrome 3 (MCAHS3) approved 615398
Multiple Endocrine Neoplasia Type 2A (MEN 2A) approved 171400